Despite cutting-edge vaccines and treatments, one of the most effective ways to stay on top of COVID-19 surges relies on a decidedly basic entity: human waste. Biobot, co-founded by Massachusetts Institute of Technology biologist Mariana Matus and urban-studies researcher Newsha Ghaeli, is the first company to analyze human waste—which can provide an early warning of an impending spike in COVID-19 cases—on a commercial basis. Its technology, which can detect pathogens as well as other substances of interest (like opioids), is now in use at more than 700 sewage sites serving more than 100 million people.
A weekly newsletter featuring conversations with the world’s top CEOs, managers, and founders. Join the Leadership Brief.
More Must-Reads From TIME
- What We Know So Far About the Deadly Earthquakes in Turkey and Syria
- Beyoncé's Album of the Year Snub Fits Into the Grammys' Long History of Overlooking Black Women
- How the U.S. Shot Down the Alleged Chinese Spy Balloon
- Effective Altruism Has a Toxic Culture of Sexual Harassment and Abuse, Women Say
- Inside Bolsonaro's Surreal New Life as a Florida Man—and MAGA Darling
- 'Return to Office' Plans Spell Trouble for Working Moms
- 8 Ways to Read More Books—and Why You Should
- Why Aren't Movies Sexy Anymore?
- How Logan Paul's Crypto Empire Fell Apart
